Clinical trial
Study of the Safety and Effectiveness of Rabeprazole in Treatment of…
NCT00216450 · Janssen Cilag Pharmaceutica S.A.C.I., Greece, Industry · Completed
Key facts
| NCT number | NCT00216450 |
|---|---|
| Title | Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults. |
| Official title | An Open Observational Study For The Rabeprazole Administration In Adult Subjects With Helicobacter Pylori (H. Pylori) Infection |
| Lead sponsor | Janssen Cilag Pharmaceutica S.A.C.I., Greece, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Helicobacter Infections, Bacterial Infections |
| Intervention type | Drug |
| Interventions | rabeprazole sodium |
| Enrollment | 80 |
| Start date | Oct 1, 2004 |
| Completion | Feb 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Apr 26, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: